S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom

AMERISAFE (AMSF) Earnings Date, Estimates & Call Transcripts

$48.65
-0.20 (-0.41%)
(As of 04/17/2024 ET)

Earnings Summary

Upcoming
Earnings Date
Apr. 24
After Market Closes
Confirmed
Actual EPS
(Feb. 21)
$0.74 Beat By $0.08
Consensus EPS
(Feb. 21)
$0.66
Skip Charts & View Estimated and Actual Earnings Data

AMSF Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

AMSF Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

AMERISAFE Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20241$0.63$0.63$0.63
Q2 20241$0.60$0.60$0.60
Q3 20241$0.61$0.61$0.61
Q4 20241$0.62$0.62$0.62
FY 20244$2.46$2.46$2.46
Q1 20251$0.60$0.60$0.60
Q2 20251$0.56$0.56$0.56

AMSF Earnings Date and Information

AMERISAFE last posted its quarterly earnings data on February 21st, 2024. The insurance provider reported $0.74 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.66 by $0.08. The firm had revenue of $73.88 million for the quarter, compared to the consensus estimate of $75.15 million. AMERISAFE has generated $3.23 earnings per share over the last year ($3.23 diluted earnings per share) and currently has a price-to-earnings ratio of 15.1. Earnings for AMERISAFE are expected to decrease by -9.72% in the coming year, from $2.47 to $2.23 per share. AMERISAFE has confirmed that its next quarterly earnings report will be published on Wednesday, April 24th, 2024. AMERISAFE will be holding an earnings conference call on Thursday, April 25th at 10:30 AM Eastern. Interested parties can register for or listen to the call..

AMERISAFE Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
4/24/2024
Confirmed)
-------  
2/21/2024Q4 2023$0.66$0.74+$0.08$0.48$75.15 million$73.88 million
10/25/2023Q3 2023$0.64$0.61($0.03)$0.70$75.00 million$74.82 million
7/27/2023Q2 2023$0.69$0.73+$0.04$0.65$75.34 million$73.54 million
4/26/2023Q1 2023$0.66$0.83+$0.17$0.76$74.46 million$76.81 million
2/21/2023Q4 2022$0.65$0.84+$0.19$0.60$73.59 million$79.76 million    
10/26/2022Q3 2022$0.58$0.73+$0.15$0.87$72.33 million$74.88 million
7/28/2022Q2 2022$0.59$0.68+$0.09$1.04$70.89 million$76.90 million    
4/27/2022Q1 2022$0.61$0.82+$0.21$0.75$72.00 million$73.78 million    
10/26/2021Q3 2021$0.77$1.02+$0.25$1.05$76.42 million$73.82 million    
7/27/2021Q2 2021$0.73$1.04+$0.31$0.85$78.04 million$76.69 million    
4/29/2021Q1 2021$0.73$0.76+$0.03$0.53$78.79 million$77.52 million  

AMERISAFE Earnings - Frequently Asked Questions

When is AMERISAFE's earnings date?

AMERISAFE has confirmed that its next quarterly earnings data will be published on Wednesday, April 24th, 2024. Learn more on AMSF's earnings history.

Did AMERISAFE beat their earnings estimates last quarter?

In the previous quarter, AMERISAFE (NASDAQ:AMSF) reported $0.74 earnings per share (EPS) to beat the analysts' consensus estimate of $0.66 by $0.08. Learn more on analysts' earnings estimate vs. AMSF's actual earnings.

How much revenue does AMERISAFE generate each year?

AMERISAFE (NASDAQ:AMSF) has a recorded annual revenue of $306.85 million.

How much profit does AMERISAFE generate each year?

AMERISAFE (NASDAQ:AMSF) has a recorded net income of $62.11 million. AMSF has generated $3.23 earnings per share over the last four quarters.

What is AMERISAFE's price-to-earnings ratio?

AMERISAFE (NASDAQ:AMSF) has a trailing price-to-earnings ratio of 15.06 and a forward price-to-earnings ratio of 19.70.

What is AMERISAFE's EPS forecast for next year?

AMERISAFE's earnings are expected to decrease from $2.47 per share to $2.23 per share in the next year, which is a -9.72% change.


More Earnings Resources from MarketBeat

This page (NASDAQ:AMSF) was last updated on 4/17/2024 by MarketBeat.com Staff

From Our Partners